0000950170-24-084656.txt : 20240718 0000950170-24-084656.hdr.sgml : 20240718 20240718172028 ACCESSION NUMBER: 0000950170-24-084656 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240716 FILED AS OF DATE: 20240718 DATE AS OF CHANGE: 20240718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERMAN DENNIS N CENTRAL INDEX KEY: 0001273858 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39676 FILM NUMBER: 241125474 MAIL ADDRESS: STREET 1: 9605 SCRANTON RD STREET 2: STE 240 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc. CENTRAL INDEX KEY: 0001750149 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263407249 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 678-392-3419 MAIL ADDRESS: STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 ownership.xml 4 X0508 4 2024-07-16 0001750149 Inhibikase Therapeutics, Inc. IKT 0001273858 BERMAN DENNIS N 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 true false false false false Stock Option (right to buy) 1.54 2024-07-16 4 A false 30000 0.00 A 2031-07-16 Common Stock 30000 30000 I By Molino Ventures, LLC The options will vest on the earlier of July 16, 2025 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date. /s/ Milton H. Werner, attorney-in-fact 2024-07-18